Dr. Joseph Han
Claim this profileGSK Investigational Site
Studies Sinusitis
Studies Chronic Sinusitis
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Joseph Han is currently running
Lebrikizumab
for Rhinosinusitis with Nasal Polyps
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
Recruiting1 award Phase 35 criteria
Depemokimab vs Mepolizumab
for Granulomatosis with Polyangiitis
This trial is testing two medications, depemokimab and mepolizumab, to see if they can help adults with a difficult-to-treat inflammatory condition called EGPA by reducing inflammation. Mepolizumab was previously approved for the treatment of EGPA.
Recruiting1 award Phase 38 criteria
More about Joseph Han
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Joseph Han has experience with
- Depemokimab
- Mepolizumab
- Depemokimab (GSK3511294)
- Lebrikizumab
Breakdown of trials Joseph Han has run
Chronic Sinusitis
Granulomatosis with Polyangiitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph Han specialize in?
Joseph Han focuses on Sinusitis and Chronic Sinusitis. In particular, much of their work with Sinusitis has involved treating patients, or patients who are undergoing treatment.
Is Joseph Han currently recruiting for clinical trials?
Yes, Joseph Han is currently recruiting for 2 clinical trials in Norfolk Virginia. If you're interested in participating, you should apply.
Are there any treatments that Joseph Han has studied deeply?
Yes, Joseph Han has studied treatments such as Depemokimab, Mepolizumab, Depemokimab (GSK3511294).
What is the best way to schedule an appointment with Joseph Han?
Apply for one of the trials that Joseph Han is conducting.
What is the office address of Joseph Han?
The office of Joseph Han is located at: GSK Investigational Site, Norfolk, Virginia 23507 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.